Public R&D Investments and Private-sector Patenting: Evidence from NIH Funding Rules

被引：114

作者：

Azoulay, Pierre ^{[1
,2
]}

Zivin, Joshua S. Graff ^{[2
,3
]}

Li, Danielle ^{[1
,2
]}

Sampat, Bhaven N. ^{[2
,4
]}

机构：

[1] MIT, Cambridge, MA 02139 USA

[2] NBER, Cambridge, MA 02138 USA

[3] UCSD, La Jolla, CA USA

[4] Columbia Univ, New York, NY 10027 USA

来源：

REVIEW OF ECONOMIC STUDIES | 2019年 / 86卷 / 01期

基金：

美国国家科学基金会;

关键词：

Economics of science; Patenting; Academic research; NIH; Knowledge spillovers; KNOWLEDGE TRANSFER; TECHNOLOGY; UNIVERSITIES; SPILLOVERS; RETURNS; PRODUCTIVITY; COMPLEMENT; INNOVATION; CITATIONS; BENEFITS;

D O I：

10.1093/restud/rdy034

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

We quantify the impact of scientific grant funding at the National Institutes of Health (NIH) on patenting by pharmaceutical and biotechnology firms. Our article makes two contributions. First, we use newly constructed bibliometric data to develop a method for flexibly linking specific grant expenditures to private-sector innovations. Second, we take advantage of idiosyncratic rigidities in the rules governing NIH peer review to generate exogenous variation in funding across research areas. Our results show that NIH funding spurs the development of private-sector patents: a $10 million boost in NIH funding leads to a net increase of 2.7 patents. Though valuing patents is difficult, we report a range of estimates for the private value of these patents using different approaches.

引用

页码：117 / 152

页数：36

共 50 条

[21] Aggregate private R&D investments in agriculture: The role of incentives, public policies, and institutions
Alfranca, O
Huffman, WE
ECONOMIC DEVELOPMENT AND CULTURAL CHANGE, 2003, 52 (01) : 1 - 21
[22] R&D Investments and Firm Value: Evidence from China
Kim, Woo Sung
Park, Kunsu
Lee, Sang Hoon
Kim, Hongyoung
SUSTAINABILITY, 2018, 10 (11):
[23] Trust and R&D investments: evidence from OECD countries
Ndubuisi, Gideon
JOURNAL OF INSTITUTIONAL ECONOMICS, 2020, 16 (06) : 809 - 830
[24] Public R&D under different electoral rules: evidence from OECD countries
Kruminas, Pijus
CONSTITUTIONAL POLITICAL ECONOMY, 2019, 30 (03) : 300 - 329
[25] Public R&D under different electoral rules: evidence from OECD countries
Pijus Krūminas
Constitutional Political Economy, 2019, 30 : 300 - 329
[26] Public funding and private investment for R&D: a survey in China's pharmaceutical industry
Qiu, Lan
Chen, Zi-Ya
Lu, Deng-Yu
Hu, Hao
Wang, Yi-Tao
HEALTH RESEARCH POLICY AND SYSTEMS, 2014, 12
[27] Public funding and private investment for R&D: a survey in China’s pharmaceutical industry
Lan Qiu
Zi-Ya Chen
Deng-Yu Lu
Hao Hu
Yi-Tao Wang
Health Research Policy and Systems, 12
[28] Publicly funded R&D for public sector performance and efficiency: evidence from Europe
Maroto, Andres
Gallego, Jorge
Rubalcaba, Luis
R & D MANAGEMENT, 2016, 46 : 564 - 578
[29] THE ETHICAL STANDARDS CLAUSE - A LESSON FROM THE PRIVATE-SECTOR FOR THE PUBLIC-SECTOR
BRIGGS, S
SIEGELE, MH
JOURNAL OF COLLECTIVE NEGOTIATIONS IN THE PUBLIC SECTOR, 1994, 23 (03) : 181 - 186
[30] Do R&D subsidies stimulate or displace private R&D? Evidence from Israel
Lach, S
JOURNAL OF INDUSTRIAL ECONOMICS, 2002, 50 (04): : 369 - 390

← 1 2 3 4 5 →